Search results for "Anesthesia"

showing 10 items of 2277 documents

Heterogeneity of P2-Purinoceptors in Brain Circulation

1990

The existence of P2-purinoceptors in the cerebrovascular bed was examined by testing the effects of ATP and its stable analog, α,β-methylene-ATP, on CBF in the unanesthetized goat as well as on isometric tension in isolated goat middle cerebral artery. When injected directly into the cerebral circulation, ATP increased and α,β-methylene-ATP decreased CBF. Indomethacin did not modify either of these effects. The vasoconstrictor action of α,β-methylene-ATP was reduced by nicardipine. “In vitro,” both ATP and α,β-methylene-ATP contracted the cerebral arteries at resting tone, but the analog was more potent than ATP. Repeated application of α,β-methylene-ATP as well as indomethacin significant…

P2Y receptorGoatsIndomethacinPurinergic receptorCerebral arteriesReceptors PurinergicCerebral ArteriesBiologyPharmacologyCerebral circulationAdenosine TriphosphateNeurologyVasoconstrictionCerebrovascular Circulationmedicine.arteryAnesthesiaMiddle cerebral arteryCirculatory systemmedicineAnimalsPotencyFemaleNeurology (clinical)Cardiology and Cardiovascular MedicineReceptorJournal of Cerebral Blood Flow & Metabolism
researchProduct

Bilateral Transcranial Magnetic Stimulation of the Prefrontal Cortex Reduces Cocaine Intake: A Pilot Study

2016

Background Chronic cocaine consumption is associated with a decrease in mesolimbic dopamine transmission that maintains drug intake. transcranial magnetic stimulation (TMS) is gaining reliability, a useful therapeutic tool in drug addiction, since it can modulate cortico-limbic activity resulting in reduction of drug craving. Aims In the present study, we investigated the therapeutic effect of bilateral TMS of prefrontal cortex (PFC) in reducing cocaine intake, in a sample of treatment-seeking patients with current cocaine use disorder (DSM-V). Methods Ten cocaine addicts (DSM-V) were randomly assigned to the active or sham stimulation protocol in a double-blind experimental design. Twelve …

PFClcsh:RC435-571medicine.medical_treatmentmedia_common.quotation_subjectDopamineStimulation03 medical and health sciences0302 clinical medicineCocaine use disorder; Dopamine; PFC; rTMS;CocaineDopaminelcsh:PsychiatryrTMSmedicinePrefrontal cortexripetitive transcranial magnetic stimulationOriginal Researchmedia_commoncocaine use disorder dopamine PFC rTMSPsychiatryprefrontal cortex (PFC)AddictionTherapeutic effectRepeated measures design030227 psychiatryCocaine use disorderTranscranial magnetic stimulationPsychiatry and Mental healthAnesthesiaAnalysis of variancePsychology030217 neurology & neurosurgerymedicine.drug
researchProduct

The perioperative management of small animals with previously implanted pacemakers undergoing anaesthesia.

2020

Abstract Objective There is little information in the veterinary literature about the perioperative management of small animal patients with previously implanted pacemakers undergoing elective or emergency non-cardiac procedures. The purpose of this article is to review the current literature with regard to human patients, with previously implanted pacemakers, undergoing general anaesthesia. Using this and the current information on pacemakers and anaesthesia in dogs and cats, we provide recommendations for small animal patients in this situation. Databases used Google Scholar, PubMed and CAB Abstracts using and interlinking and narrowing the search terms: “dog”, “cat”, “small animals”, “an…

Pacemaker ArtificialGeneral VeterinaryPerioperative managementbusiness.industryPerioperativeAnesthesia GeneralCat DiseasesIntensive care unitlaw.inventionTransvenous pacingDogslawAnesthesiologyAnesthesiaPerioperative careCatsMedicineAnimalsHumansGeneral anaesthesiaPacemaker PlacementDog DiseasesbusinessImplanted pacemakerVeterinary anaesthesia and analgesia
researchProduct

Peripheral Acute Pain Mechanisms

1995

Many studies in several species, including humans, have identified a subset of primary afferent nerve fibres that are activated by potential or actual tissue-damaging stimuli. Discharge patterns of these nociceptive afferents faithfully reproduce some aspects of the applied stimuli (e.g. shape of the stimulus-response function) but not others (e.g. time-course of a sustained stimulus). Since primary nociceptive afferents provide the input to the central nervous system, their encoding properties have to be considered when studying central processing. On the other hand, pain perception correlates with some aspects of nociceptor discharges (e.g. fatigue with repetition of brief heat pulses), b…

Pain ThresholdAfferent PathwaysPain Postoperativebusiness.industryCentral nervous systemNociceptorsPainStimulationGeneral MedicineStimulus (physiology)PeripheralNociceptionmedicine.anatomical_structureHyperalgesiaAnesthesiaAcute DiseaseHyperalgesiamedicineNociceptorAnimalsHumansmedicine.symptombusinessNeuroscienceSensitizationAnnals of Medicine
researchProduct

Combining transcranial magnetic stimulation and subdural electrodes for pain modulation

2017

Pain modulationbusiness.industrymedicine.medical_treatment05 social sciencesPainSubdural SpaceTranscranial Magnetic Stimulation050105 experimental psychologySensory SystemsTranscranial magnetic stimulation03 medical and health sciences0302 clinical medicineText miningNeurologyPhysiology (medical)AnesthesiamedicineHumans0501 psychology and cognitive sciencesNeurology (clinical)businessSubdural electrodesElectrodes030217 neurology & neurosurgeryClinical Neurophysiology
researchProduct

COX-2 inhibition and pain management: a review summary

2005

Cyclooxygenase-2 selective inhibitors have long been regarded as potent anti-inflammatory drugs for the treatment of arthritis, osteoarthritis and dysmenorrhea. The reports of cardiovascular risk and the subsequent withdrawal of rofecoxib, and recently valdecoxib, has called the therapeutic potential of coxibs into question. Currently, according to the latest decisions of the US Food and Drug Administration and European Medicines Agency, the approval of valdecoxib has been refused for 1 year due to an increased rate of cardiovascular risks and serious skin reactions. There are restrictions concerning the use of all other coxibs. The short-time use of coxibs, however, in anti-inflammatory tr…

Pain modulationmedicine.medical_specialtybusiness.industryImmunologyArthritisPerioperativeOsteoarthritisPain managementmedicine.diseaseValdecoxibFood and drug administrationAnesthesiamedicineImmunology and AllergyIntensive care medicinebusinessRofecoxibmedicine.drugExpert Review of Clinical Immunology
researchProduct

The direct effect of magnetic tape ® on pain and lower-extremity blood flow in subjects with low-back pain: A randomized clinical trial

2021

Low-back pain has a high impact on the world population, and solutions are in demand. The behavior of specific physiological processes has been modified using magnetic fields, whether for pain relief, bone consolidation, or improvement of vascularization. The use of tape with magnetic properties could help in these cases. A double-blind randomized clinical trial was designed to use Magnetic Tape® versus placebo Kinesio tape. Blood flow variables were evaluated using pulsed power Doppler ultrasound. Resistance index, pulsatility index, systolic velocity, and diastolic velocity were measured. The pressure pain threshold was measured using algometry in 22 subjects. The results reveal significa…

Pain reliefDiastoleMagnetic tapeTP1-1185Pulsatility indexPlaceboBiochemistryArticleAnalytical Chemistrylaw.inventionMagnetic TapeRandomized controlled trialLow-back painlawPower pulsed DopplerMedicineHumansElectrical and Electronic EngineeringInstrumentationFisioterapiaPressure pain thresholdbusiness.industryChemical technologyMagnetic PhenomenaHemodynamicsExtremitiesBlood flowLow back painAtomic and Molecular Physics and OpticsAthletic TapeAnesthesiamedicine.symptombusinessLow Back Painhuman activitiesPhysical therapy
researchProduct

Intravenous morphine for management of cancer pain.

2010

Summary In recent years, a growing interest in palliative care and in routes of administration other than oral have prompted more aggressive measures to improve the efficacy of analgesic interventions in patients with difficult pain conditions. This review provides an overview of the use of intravenous morphine to control pain in patients with cancer. Intravenous morphine has been increasingly used in different clinical situations—including breakthrough pain, poor pain control with escalating doses of oral opioids, retitrating patients with acute pain, treating patients with long-standing poor pain control and unpredictable needs, and optimising opioid therapy to prevent incident pain assoc…

Palliative careDose-Response Relationship DrugMorphinebusiness.industryAnalgesicPsychological interventionCancerPainmedicine.diseasePain ladderAnalgesics OpioidOncologyOpioidAnesthesiaNeoplasmsChronic DiseaseInjections IntravenousMorphineMedicineHumansbusinessCancer painmedicine.drugPain MeasurementThe Lancet. Oncology
researchProduct

Analgesic Treatment of Bone Metastases

2013

The presence of bone metastases predicts the presence of pain and is the most common cause of cancer-related pain. Although bone metastases do not involve vital organs, they may determine deleterious effects in patients with prolonged survival. Bone fractures, hypercalcaemia, neurologic deficits and reduced activity associated with bone metastases result in an overall compromise in the patient’s quality of life. A metastasis is a consequence of a cascade of events including a progressive growth at the primary site, vascularization phase, invasion, detachment, embolization, survival in the circulation, arrest at the site of a metastasis, extravasion, evasion of host defense and progressive g…

Palliative careHypercalcaemiaNerve rootbusiness.industryAnalgesicmedicine.diseaseMetastasisBone remodelingmedicine.anatomical_structureOsteoclastAnesthesiamedicinemedicine.symptombusinessmuscle spasm
researchProduct

Opioid Poorly-Responsive Cancer Pain. Part 1

2001

Pain that is poorly responsive to opioid analgesics is challenging for physicians who deal with cancer patients. Numerous factors may influence analgesic response during the course of the illness. These include changing nociception associated with disease progression, the appearance of intractable side effects, the development of tolerance, the presence of neuropathic pain, the temporal pattern, the effects produced by the production of opioid metabolites, and many others. These factors influence the delicate balance between pain relief and opioid toxicity that must be achieved in cancer patients with pain.

Palliative carebusiness.industryAnalgesicCancerBioinformaticsmedicine.diseasePain ladderAnesthesiology and Pain MedicineNociceptionOpioidAnesthesiaNeuropathic painmedicineNeurology (clinical)Cancer painbusinessGeneral Nursingmedicine.drugJournal of Pain and Symptom Management
researchProduct